Replies to post #859 on Enanta Pharmaceuticals Inc (ENTA)

[steveporsche]

Hard to believe the stock traded at $57 during the pre-market on the day the ESRX contract was announced. The stock is trading roughly where it was a year ago. Recent news flow has been good IMO. Friday ABBV basically guides that they will be paying ENTA $37 million plus in royalties in Q4 2015 on over $750 million of V-P Q4 sales with growth anticipated from there in 2016. Co. will be exiting 2015 with a cash hoard of several hundred million dollars in cash. Co. has a pipeline. $800 million market cap. Does not compute.

[semi_infinite]

My guess is that this is due for a bounce because it is close to prior monthly lows in Dec and Nov.